Literature DB >> 9206982

Recent advances in lymphocyte signaling and regulation.

C Kung1, M L Thomas.   

Abstract

The antigen receptor signaling pathway in lymphocytes is vital to their development and biological function. Recent studies have shown that protein tyrosine kinases and phosphatases are essential components in this receptor signaling pathway and therefore, are critical for the development of mature and functionally competent lymphocytes. The Src kinase family of protein tyrosine kinases coordinates the early signaling events in antigen receptor signaling via phosphorylation of tyrosine-based substrates. These kinases are regulated by the concerted action of the Csk family of non-receptor protein tyrosine kinases and the protein tyrosine phosphatase, CD45. A complex set of phosphorylation and dephosphorylation events regulate protein tyrosine kinase activity. Upon antigen stimulation, Src protein tyrosine kinases in conjunction with the tyrosine kinases, ZAP-70 and Syk initiate downstream effectors leading to Ca2+ mobilization, the activation of the Ras pathway and transcriptional activation. The roles of the various adapter proteins in these pathways are now being elucidated. It is apparent that a network of phosphorylation events connect the antigen receptor to intracellular signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9206982     DOI: 10.2741/a184

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  2 in total

1.  4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8+ T cell proliferation.

Authors:  Beom K Choi; Do Y Lee; Don G Lee; Young H Kim; Seon-Hee Kim; Ho S Oh; Chungyong Han; Byoung S Kwon
Journal:  Cell Mol Immunol       Date:  2016-03-14       Impact factor: 11.530

2.  RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells.

Authors:  Jung Sun Park; Hoon-In Choi; Dong-Hyun Kim; Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Int J Mol Sci       Date:  2019-11-04       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.